Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DR26FBQEB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,933
Award facts
- Contract value 100% obligated
- $9,932.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order with a $9,932.50 ceiling to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 29, 2026, for ENTYVIO 300 MG VIALS. The order is firm-fixed-price, carries no set-aside, and reaches ultimate completion on July 30, 2026. Place of performance is Park Ridge, IL 60068, USA.
Quick answers
Who was awarded contract SPE2DR26FBQEB?
SPE2DR26FBQEB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2026.
How much is contract SPE2DR26FBQEB worth?
The government has obligated $9,933 on SPE2DR26FBQEB.
Is contract SPE2DR26FBQEB an order under another contract?
Yes. SPE2DR26FBQEB is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBQEB competed?
The extent of competition for SPE2DR26FBQEB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award